HeartFlow Analysis vs ZEUS System (Zio Watch)
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, AI-powered solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models from standard CT scans. This tool is ideal for assessing the functional impact of coronary blockages (FFRct) and quantifying plaque, providing precise insights to guide treatment decisions without invasive procedures.
View HeartFlow Analysis →Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if your patient needs long-term, continuous cardiac monitoring to detect and characterize intermittent arrhythmias, such as Atrial Fibrillation (AFib). This wearable device is best suited for patients experiencing symptoms suggestive of arrhythmias or those at risk, where extended monitoring is crucial to capture elusive events and provide actionable insights for physicians.
View ZEUS System (Zio Watch) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | ZEUS System (Zio Watch) |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact vendor |
| Deployment | Cloud-based (AWS) | Cloud-based system with a wearable device |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool B (ZEUS System) offers a more comprehensive approach to usability, featuring a wearable device for patients, a dedicated patient app (MyZiou00ae) for logging symptoms and education, and a provider portal and mobile app (ZioSuiteu00ae) for report interpretation and patient management. This broad ecosystem addresses usability across a wider range of users, including direct patient engagement.
Clinical Value
HeartFlow AnalysisTool A (HeartFlow Analysis) provides a non-invasive alternative to invasive coronary angiography with FFR, offering detailed physiological assessment of coronary artery disease (CAD) severity and potentially reducing unnecessary invasive procedures. Its high diagnostic accuracy and ability to impact interventional decision-making represent significant clinical value.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis (Tool A) has established Category I CPT codes for FFRct Analysis and AI-Enabled Quantitative Plaque Analysis, with clear Medicare and most U.S. commercial payer coverage and established CMS payment rates. This transparency and established reimbursement pathway significantly enhance its financial value proposition for providers compared to Tool B, which lacks specific pricing or reimbursement details.
Enterprise Readiness
HeartFlow AnalysisBoth tools demonstrate strong foundational enterprise readiness with FDA clearance, HIPAA compliance, and cloud-based deployments. However, HeartFlow Analysis (Tool A), being a purely software-based solution that processes existing CT scans, likely offers a simpler integration path into existing hospital IT infrastructure without the additional logistical complexities of managing and distributing physical wearable devices, as required by Tool B.
Innovation
HeartFlow AnalysisHeartFlow Analysis (Tool A) demonstrates a higher degree of scientific and engineering innovation by combining AI with advanced computational fluid dynamics (CFD) to non-invasively derive Fractional Flow Reserve (FFRct) from standard CT scans. This complex integration provides a physiological assessment traditionally requiring an invasive procedure, representing a significant technological leap.
Support & Docs
TieNeither the provided structured facts nor readily available web searches offer specific comparative details regarding the depth, responsiveness, or quality of support and documentation for either tool. As both are commercial-stage, FDA-cleared medical technologies, it is reasonable to assume they both provide standard levels of customer support and necessary documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | ZEUS System (Zio Watch) |
|---|---|---|
| Tool Name | HeartFlow Analysis | ZEUS System (Zio Watch) |
| Company | HeartFlow | iRhythm Technologies |
| Primary Use Case | Non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | Long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias. |
| Key Diagnostic/Monitoring Capability | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization). | Wearable biosensor for continuous ECG and PPG data collection, AI-powered algorithm for advanced arrhythmia detection and analysis, detects and characterizes Atrial Fibrillation (AFib) burden. |
| Target Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
| Core Technology | Software and artificial intelligence (AI), Computational Fluid Dynamics (CFD). | AI-powered wearable biosensor (Zio Watch) for continuous ECG and PPG data collection, AI-powered algorithm (ZEUS System). |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and ZEUS System (Zio Watch).
Frequently Asked Questions
More Comparisons
More matchups featuring HeartFlow Analysis or ZEUS System (Zio Watch)
Backers
Who funded each tool's parent company.